Rescue therapy with tacrolimus in simultaneous pancreas/kidney transplantation

Transplant International

Volumn 10, Issue 1, 1997, Pages 51-54

  Backer, G ^a   Witzke, O ^a   Wagner, K ^a   Philipp, T ^a   Heemann, U ^a   Friedrich, J ^a   Albrecht, K H ^a  

^a UNIVERSITY HOSPITAL ESSEN   (Germany)

Author keywords

Kidney pancreas transplantation, rescue therapy; Pancreas kidney transplantation, tacrolismus, rescue therapy; Rescue therapy, tacrolismus, kidney pancreas transplantation Tacrolimus, kidney pancreas transplantation

Indexed keywords

CREATININE; CYCLOSPORIN A; GLUCOSE; IMMUNOSUPPRESSIVE AGENT; INSULIN; TACROLIMUS;

ADULT; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; GLUCOSE BLOOD LEVEL; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; MALE; MYCOTIC ANEURYSM; ORAL DRUG ADMINISTRATION; PANCREAS TRANSPLANTATION; PRIORITY JOURNAL;

EID: 0031060149     PISSN: 09340874     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1432-2277.1997.tb00536.x     Document Type: Article

References (22)

1. Alloway RR, Russell WC, Gaber LAV, Amiri MH, Vera SR, Gaber AO (1996) Conversion from cyclosporine to tacrolimus in kidney, kidney/pancreas, and pancreas alone transplant recipients: the Memphis experience. Transplant Proc 28: 995-997
2. Burke GW, Alejandro R, Cianco G, Nery J, Roth D, Shapiro R, Scantlebury V, Skyler JS, Ricordi C, Tzakis A, Miller J (1995) The use of FK 506 in simultaneous pancreas/kidney transplantation: rescue, induction, and maintenance immunosuppression. Transplant Proc 27: 3123-3124
3. European FK506 multicenter liver study group (1994) Randomized trial comparing tacrolimus (FK506) and cyclosporin in prevention of liver allograft rejection. Lancet 344: 423-4125
4. Gruessner RWG, Burke GW, Stratta R, Solllinger H, Benedetti E, Marsh C, Stock P, Boudrex P, Martin M, Drangstveit MB, Sutherland DER, Gruessner A (1996) A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation. Transplantation 61:261-273
5. Jordan ML, Shapiro R, Scantlebury VP, Fung J, Tzakis A, McCauley J, Jain A, Demetris J, Randhawa P (1991) FK 506 conversion of renal allografts failing cyclosporine immunosuppression. Transplant Proc 23: 3078-3081
6. Jordan ML, Shapiro R, Vivas CA, Scantlebury VP, Darras FS, Carrieri G, McCauley J, Demetris AJ, Randhawa P, Jensen C (1993) FK 506 salvage of renal allografts with ongoing rejection failing cyclosporine immunosuppression. Transplant Proc 25: 638-640
7. Jordan ML, Shapiro R, Vivas CA, Scantlebury VP, Rhandhawa P, Carrieri G, McCauley J, Demetris AJ, Tzakis A, Fung JJ, Simmons RL, Hakala TR, Starzl TE (1994) FK506 rescue for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation 57: 860-864
8. Klintmalm GBG, Goldstein R, Gonwa T, Wiesner RH, Krom RA, Shaw BW, Stratta R, Ascher NL, Roberts JWV, Lake J, U.S. Multicenter FK 506 study group (1993) Use of Prograf (FK 506) as rescue therapy for refractory rejection after liver transplantation. Transplant Proc 25: 679-688
9. Krentz AJ, Dmitrewski J, Mayer D, McMaster P, Buckels J, Dousset B, Cramb R, Smith JM, Nattrass M (1994) Postoperative glucose metabolism in liver transplant recipients: a two-year prospective randomized study of cyclosporine versus FK506. Transplantation 57:1666-1669
10. Lewis WD, Jenkins RL, Burke PA, Winn KM, Shaffer D, Lopez R, Monaco AP (1991) FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection. Transplant Proc 23: 2989-2991
11. Oh CS, Stratta RJ, Fox BC, Sollinger HW, Beizer FO, Maki DG (1988) Increased infections associated with the use of OKT3 for treatment of steroidresistant rejection in renal transplantation. Transplantation 45: 68-73
12. Rilo M, Zeng Y, Alejandro R (1991) Effect of FK506 on function of human islets of Langerhans. Transplant Proc 23:3164-3165
13. Rosen CB, Frohnert PP, Velosa JA, Engen DE, Sterioff S (1991) Morbidity of pancreas transplantation during cadaveric renal transplantation. Transplantation 51:123-127
14. Scantlebury VP, Shapiro R, Fung J, Tzakis A, McCauley J, Jordan M, Jensen C, Hakala T, Simmons R, Starzl TE (1991) New onset diabetes in FK 506 vs cyclosporine-treated kidney transplant recipients. Transplant Proc 23: 3169-3170
15. Shaffer D, Madras PN, Sahyoun AI, Williams ME, Kaldany A, D'Elia JA, Monaco AP (1992) Combined kidney and pancreas transplantation: a 3 year experience. Arch Surg 127:574-578
16. Shaffer D, Simpson MA, Conway P, Madras PN, Monaco AP (1995) Normal pancreas allograft function following simultaneous pancreas kidney transplantation after rescue therapy with tacrolimus (FK506). Transplantation 59:1063-1066
17. Stratta RJ, Taylor P, Castaldo P, Sindhi R, Sudan D, Weide LG, Frisbie K, Gushing KA, Jerius J, Radio SJ (1996) FK 506 induction and rescue therapy in pancreas transplant recipients. Transplant Proc 28:991-992
18. Tabasco-Minguillan J, Mieles L, Caroll R, Gavaler J, Van Theil DH, Starzl TE (1993) Long-term insulin requirement after liver transplantation with FK 506 in American veterans. Transplant Proc 25:677-678
19. Teraoka S, Babazono T, Koike T, Abe M, Kimikawa M, Shinkai M, Haruguchi H, Hirotani S, Kitajima M, Akamatsu M, Ozaki M, Fujita S, Nakajima I, Kawai T, Fuchinoue S, Ota K, Tomonaga O, Yano K, Tasaka Y, Omori Y (1995) Effect of rescue therapy using FK 506 on relapsing rejection after combined pancreas and kidney transplantation. Transplant Proc 27:1335-1339
20. Tze WJ, Tai J, Murase N, Tzakis A, Starzl TE (1991) Effect of FK 506 on glucose metabolism'and insulin secretion in normal rats. Transplant Proc 23: 3158-3160
21. U.S. Multicenter FK 506 liver study group (1994) A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med331:1110-1115
22. Wadström J, Brekke B, Wrammer L, Ekberg H, Tyden G (1995) Triple versus quadruple induction immunosuppression in pancreas transplantation. Transplant Proc 27:1317-1318